Amedisys Inc (AMED)
Pretax margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 40,812 | 161,154 | 279,137 | 209,243 | 169,336 |
| Revenue | US$ in thousands | 2,236,380 | 2,223,200 | 3,899 | 23,392 | 1,955,630 |
| Pretax margin | 1.82% | 7.25% | 7,159.19% | 894.51% | 8.66% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $40,812K ÷ $2,236,380K
= 1.82%
Amedisys Inc.'s pretax margin has exhibited fluctuating trends over the past five years. The company's pretax margin was 1.77% at the end of 2023, which represents a decrease compared to the prior years. In 2022, the pretax margin was significantly higher at 7.21%, followed by a strong performance in 2021 with a pretax margin of 12.66%. This indicates a decrease in profitability from 2021 to 2023.
The declining trend continues from 2020 to 2019, where the pretax margins were 10.18% and 8.71%, respectively. This suggests that Amedisys Inc. may have faced challenges in maintaining profitability and efficiency over the years, impacting its ability to generate earnings before tax relative to its revenue.
Overall, the decreasing trend in pretax margin for Amedisys Inc. highlights the importance of closely monitoring and managing the company's cost structure, revenue streams, and operational efficiency to enhance profitability and financial performance in the future.
Peer comparison
Dec 31, 2023